3rd Dose for Immune Compromised
We are now offering 3rd doses of the Moderna and Pfizer COVID-19 vaccinations. Third doses are currently recommended by the CDC for those who may have had a low immune response to the 1st and 2nd doses and fall in the following categories. Patients that sign up for a 3rd dose will be asked to sign a self-attestation form:
- Those receiving active cancer treatment for tumors or cancers of the blood
- Those who have received an organ transplant and are taking medicine to suppress the immune system (ex. tacrolimus, cyclosporine, sirolimus, etc.)
- Those who have received a stem cell transplant within the last 2 years or are taking medicine to suppress the immune system
- Indivduals who are immunocompromised (such as DiGeorge syndrome, Wiskott-Aldrich syndrome, Rheumatoid Arthritis, Psoriasis, Type 1 Diabetes, Multiple Sclerosis, Lupus, Sjogren's Syndrome, Hashimoto's thyroiditis, Celiac Disease4, Crohn's Disease, etc.
- Individuals with HIV infection
- Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response (Daily Prednisone use > 20mg per day)(azathioprine, mycophenolate, leflunomide, Humira, Soliris, Enbrel, etc.)
For additional questions please refer to the CDC Website or call the pharmacy at (316) 321-5330 to confirm elegiblity.
Pfizer COVID-19 Vaccine booster approval
Now that the FDA has updated their EUA and CDC has signed off on it, pharmacies can now administer Pfizer booster doses to the following groups of people who received their initial two doses of Pfizer at least 6 months ago (counted from the second dose).
- people 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer,
- people aged 50–64 years with underlying medical conditions should receive a booster shot of Pfizer,
- people aged 18–49 years with underlying medical conditions may receive a booster shot of Pfizer, based on their individual benefits and risks, and
- people aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting (including health care workers) may receive a booster shot of Pfizer, based on their individual benefits and risks.
The underlying medical conditions included are:
- Chronic kidney disease
- Chronic lung disease, such as COPD, moderate to severe asthma, interstitial lung disease, cystic fibrosis, and pulmonary hypertension
- Current or former smoker
- Down syndrome
- Heart conditions, such as heart failure, CAD, cardiomyopathies, and hypertension
- Immunocompromised state
- Liver disease
- Neurological conditions, including dementia and Alzheimer’s
- Overweight and obesity
- Sickle cell disease or thalassemia
- Solid organ or stem cell transplant
- Stroke or cerebrovascular disease
- Substance use disorder
For patients who received their initial series as Moderna or Johnson and Johnson and fit into these categories, the same process of FDA approval then CDC recommendation will need to take place for them to receive their booster.